These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22252003)

  • 1. Influenza vaccination for older adults.
    Talbot HK; Libster R; Edwards KM
    Hum Vaccin Immunother; 2012 Jan; 8(1):96-101. PubMed ID: 22252003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated intranasal influenza vaccine.
    Esposito S; Montinaro V; Groppali E; Tenconi R; Semino M; Principi N
    Hum Vaccin Immunother; 2012 Jan; 8(1):76-80. PubMed ID: 22251995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
    Myers CA; Faix DJ; Blair PJ
    Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
    [No Abstract]   [Full Text] [Related]  

  • 4. Mortality benefits of influenza vaccination in elderly people.
    Thijs C; Beyer WE; Govaert PM; Sprenger MJ; Dinant GJ; Knottnerus A
    Lancet Infect Dis; 2008 Aug; 8(8):460-1; author reply 463-5. PubMed ID: 18652989
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine.
    Sullivan SJ; Jacobson R; Poland GA
    Expert Rev Vaccines; 2010 Oct; 9(10):1127-33. PubMed ID: 20923264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
    King JC; Lichenstein R; Magder LS
    Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
    Manuel O; Humar A; Berutto C; Ely L; Giulieri S; Lien D; Meylan PR; Weinkauf J; Pascual M; Nador R; Aubert JD; Kumar D
    J Heart Lung Transplant; 2011 Jun; 30(6):679-84. PubMed ID: 21377898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of influenza vaccines.
    Linder J
    N Engl J Med; 2010 Jan; 362(2):180; author reply 180-1. PubMed ID: 20077593
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy of influenza vaccines.
    Narayan KM; del Rio C
    N Engl J Med; 2010 Jan; 362(2):179-80; author reply 180-1. PubMed ID: 20071712
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 16. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.
    Madhi SA; Maskew M; Koen A; Kuwanda L; Besselaar TG; Naidoo D; Cohen C; Valette M; Cutland CL; Sanne I
    Clin Infect Dis; 2011 Jan; 52(1):128-37. PubMed ID: 21148531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing.
    Ambrose CS
    Hum Vaccin Immunother; 2012 Feb; 8(2):279; author reply 280. PubMed ID: 22426366
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.